Multivariable regression for relapse in 3 candidate KIR genotypes
Model . | G5 . | G3/HLA-Bw4 . | G2/HLA-C1C1 . | |||
---|---|---|---|---|---|---|
HR (95% CI) . | P . | HR (95% CI) . | P . | HR (95% CI) . | P . | |
CIBMTR | G5, n = 136 vs all others, n = 1881 | G3, n = 53 vs other Bw4, n = 1143 | G2, n = 86 vs other C1C1 n = 761 | |||
Base model∗ | 0.52 (0.35, 0.78) | .002 | 0.32 (0.14, 0.72) | .006 | 1.63 (1.15, 2.29) | .005 |
Int∗ T-cell depletion† | 0.55 (0.34, 0.92) | .021 | 0.50 (0.21, 1.21) | .13 | 1.35 (0.81, 2.27) | .30 |
Int∗ cond intensity | 0.43 (0.23, 0.78) | .005 | 0.17 (0.04, 0.68) | .013 | 1.93 (1.17, 3.18) | .010 |
DRST | G5, n = 73 vs all others, n = 743 | G3, n = 24 vs other Bw4, n = 451 | G2, n = 42 vs other C1C1, n = 264 | |||
1.01 (0.55, 1.85) | .97 | 0.87 (0.35, 2.17) | .76 | 0.41 (0.18, 0.96) | .041 |
Model . | G5 . | G3/HLA-Bw4 . | G2/HLA-C1C1 . | |||
---|---|---|---|---|---|---|
HR (95% CI) . | P . | HR (95% CI) . | P . | HR (95% CI) . | P . | |
CIBMTR | G5, n = 136 vs all others, n = 1881 | G3, n = 53 vs other Bw4, n = 1143 | G2, n = 86 vs other C1C1 n = 761 | |||
Base model∗ | 0.52 (0.35, 0.78) | .002 | 0.32 (0.14, 0.72) | .006 | 1.63 (1.15, 2.29) | .005 |
Int∗ T-cell depletion† | 0.55 (0.34, 0.92) | .021 | 0.50 (0.21, 1.21) | .13 | 1.35 (0.81, 2.27) | .30 |
Int∗ cond intensity | 0.43 (0.23, 0.78) | .005 | 0.17 (0.04, 0.68) | .013 | 1.93 (1.17, 3.18) | .010 |
DRST | G5, n = 73 vs all others, n = 743 | G3, n = 24 vs other Bw4, n = 451 | G2, n = 42 vs other C1C1, n = 264 | |||
1.01 (0.55, 1.85) | .97 | 0.87 (0.35, 2.17) | .76 | 0.41 (0.18, 0.96) | .041 |